SCHEMBL24669478

SCHEMBL24669478

CC(C)n1cc2ccncc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.38
HTT P42858 1/20 0.38
NCOA1 Q15788 1/20 0.38
NCOA3 Q9Y6Q9 1/20 0.38
DYRK1A Q13627 2/20 0.38
NFATC1 O95644 1/20 0.38
GSK3B P49841 1/20 0.38
HASPIN Q8TF76 2/20 0.37
LMNA P02545 2/20 0.36
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MAPKAPK2 P49137 1/20 0.34
HTR2A P28223 2/20 0.34
HTR2C P28335 2/20 0.34
HTR2B P41595 2/20 0.34
ROCK2 O75116 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL256355 0.76 HASPIN (0.43) DYRK1ANFATC1GSK3BHASPINLMNA
SCHEMBL15935200 0.71 HASPIN (0.37) DYRK1ANFATC1GSK3BHASPINLMNA
SCHEMBL24668531 0.68 HASPIN (0.35) DYRK1AGSK3BHASPINCYP1A2CYP2D6
SCHEMBL152013 0.68 CYP19A1 (0.45) HTTDYRK1ALMNACYP1A2CYP3A4
SCHEMBL19270203 0.67 KDM4C (0.36) USP2HTTNCOA1NCOA3DYRK1A
SCHEMBL19270204 0.67 KDM4C (0.39) USP2HTTNCOA1NCOA3DYRK1A
Benzene SCHEMBL27941073 0.66 PRKCZ (0.45) HTTDYRK1AHASPINLMNACYP1A2
SCHEMBL30912787 0.66 CYP19A1 (0.49) DYRK1ACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL140144 0.66 PRKCZ (0.48) HTTDYRK1AHASPINLMNACYP1A2
SCHEMBL31613470 0.66 PRKCZ (0.48) HTTDYRK1AHASPINLMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022187693-A1 COVALENT CDK2-BINDING COMPOUNDS FOR THERAPEUTIC PURPOSES UMBRA THERAPEUTICS INC. (US) 2022-09-09 WO disclosed